These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28211486)

  • 1. Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice.
    Di Pardo A; Carrizzo A; Damato A; Castaldo S; Amico E; Capocci L; Ambrosio M; Pompeo F; De Sanctis C; Spinelli CC; Puca AA; Remondelli P; Maglione V; Vecchione C
    Sci Rep; 2017 Feb; 7():42797. PubMed ID: 28211486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington's Disease Mice.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2016 Oct; 5(3):285-296. PubMed ID: 27567888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of the aryl hydrocarbon receptor in the R6/1 transgenic mouse model of Huntington's disease improves the neurological phenotype.
    Angeles-López QD; García-Lara L; Aguirre-Pineda N; Castañeda-Arellano R; Elizondo-Azuela G; Pérez-Severiano F; Segovia J
    Behav Brain Res; 2021 Jun; 408():113230. PubMed ID: 33684424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
    Dufour BD; McBride JL
    Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
    Mo C; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
    Sebastianutto I; Cenci MA; Fieblinger T
    Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of altered skeletal muscle action potentials in the R6/2 mouse model of Huntington's disease.
    Miranda DR; Reed E; Jama A; Bottomley M; Ren H; Rich MM; Voss AA
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C218-C232. PubMed ID: 32432924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington's disease.
    Morton AJ; Skillings EA; Wood NI; Zheng Z
    Sci Rep; 2019 Jan; 9(1):37. PubMed ID: 30631090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.
    Chen CM; Wu YR; Chang KH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Cl- channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington's mice.
    Miranda DR; Wong M; Romer SH; McKee C; Garza-Vasquez G; Medina AC; Bahn V; Steele AD; Talmadge RJ; Voss AA
    J Gen Physiol; 2017 Jan; 149(1):55-74. PubMed ID: 27899419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
    Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
    Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Huntington's Disease-Like Behavioral Deficits in R6/1 Mouse by Tolfenamic Acid Is Associated with Decreases in Mutant Huntingtin and Oxidative Stress.
    Liu P; Li Y; Yang W; Liu D; Ji X; Chi T; Guo Z; Li L; Zou L
    Oxid Med Cell Longev; 2019; 2019():4032428. PubMed ID: 31049134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
    Rahman A; Ekman M; Shakirova Y; Andersson KE; Mörgelin M; Erjefält JS; Brundin P; Li JY; Swärd K
    Eur J Pharmacol; 2013 Jan; 698(1-3):345-53. PubMed ID: 23117088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training normalizes mitochondrial respiratory capacity within the striatum of the R6/1 model of Huntington's disease.
    Herbst EA; Holloway GP
    Neuroscience; 2015 Sep; 303():515-23. PubMed ID: 26186895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
    Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
    PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.
    Josefsen K; Nielsen MD; Jørgensen KH; Bock T; Nørremølle A; Sørensen SA; Naver B; Hasholt L
    J Neuroendocrinol; 2008 Feb; 20(2):165-72. PubMed ID: 18034868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
    Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
    Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.